Advertisement

Topics

Global "A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)" Events Calendar

00:02 EST 16th February 2019 | BioPortfolio

We have searched our records to find all the forthcoming international "A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)" events for the next 12 months. Click on the event titles below to view the full details.

BioPortfolio's life science events and conference calendar lists forthcoming biotechnology, pharmaceutical, and medical conferences, training courses, webinars and conventions.  THIS SERVICE IS BEING UPDATED.

Showing "Study Evaluate Pharmacokinetics Safety Efficacy Omacetaxine Given Subcutaneously" Events: none exist

None

Advertisement
Quick Search
Advertisement
Advertisement